We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
151 hedge funds and large institutions have $305M invested in ANI Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 48
0.14% more ownership
Funds ownership: 55.68% → 55.82% (+0.14%)
5% less capital invested
Capital invested by funds: $320M → $305M (-$14.5M)
4% less funds holding
Funds holding: 158 → 151 (-7)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
89% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $9.86M
Holders
151
Holders Change
-7
Holders Change %
-4.43%
% of All Funds
3.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
62
Reduced
48
Closed
23
Calls
$1.11M
Puts
$9.86M
Net Calls
-$8.75M
Net Calls Change
+$6.57M
Top Buyers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$10.7M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.8M |
| 3 |
First Manhattan
New York
|
+$4.74M |
| 4 |
Morgan Stanley
New York
|
+$2.89M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.75M |
Top Sellers
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$7.56M |
| 2 |
PA
Perceptive Advisors
New York
|
-$6.25M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$5.63M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.28M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$2.89M |
